Bath & Body Works, Inc. $BBWI Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH increased its position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 342.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 117,633 shares of the company’s stock after acquiring an additional 91,070 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Bath & Body Works were worth $2,410,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. First Horizon Corp acquired a new position in Bath & Body Works during the 3rd quarter worth $29,000. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Danske Bank A S acquired a new position in Bath & Body Works during the 3rd quarter worth $39,000. Advisory Services Network LLC acquired a new position in Bath & Body Works during the 3rd quarter worth $48,000. Finally, Westfuller Advisors LLC acquired a new position in Bath & Body Works during the 3rd quarter worth $56,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

BBWI opened at $19.46 on Friday. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $34.66. The stock’s fifty day moving average is $19.89 and its 200-day moving average is $21.17. The company has a market capitalization of $3.92 billion, a PE ratio of 6.18, a P/E/G ratio of 1.83 and a beta of 1.50.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.59 billion. During the same quarter in the previous year, the business earned $2.09 EPS. The company’s quarterly revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 2.6 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend was Friday, February 20th. Bath & Body Works’s payout ratio is currently 25.40%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Monday, April 20th. Barclays boosted their price target on Bath & Body Works from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Monday, March 2nd. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and boosted their price target for the stock from $21.00 to $25.00 in a research report on Tuesday, February 17th. Zacks Research upgraded Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Tuesday, March 3rd. Three analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $23.00.

Read Our Latest Research Report on BBWI

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.